FDA grants approval for Abbott’s ALK Gene Test
Abbott (NYSE: ABT) announced that a new molecular diagnostic test has been approved by the U.S. Food and Drug Administration
Read moreAbbott (NYSE: ABT) announced that a new molecular diagnostic test has been approved by the U.S. Food and Drug Administration
Read moreEarlier on Monday, Abbott Laboratories announced that a genetic test intended to diagnose chronic lymphocytic leukemia (CLL) patients has been
Read moreLate on Wednesday, Hospira Inc. announced that William Dempsey was voted into the board of directors thus expanding the board
Read moreOn Tuesday, Abbott Laboratories announced that two longer-acting doses of Lupron, a treatment for premature puberty, have been approved by
Read more